INVOKANA
NDC 55154-1425, canagliflozin, tablet, film coated, from Cardinal Health 107, LLC.
- Product NDC
- 55154-1425
- Status
- Listed
- Labeler
- Cardinal Health 107, LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA204042
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/55154-1425 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CANAGLIFLOZIN100 mg/1
Pharmacologic classes
P-Glycoprotein Inhibitors [MoA]; Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 55154-1425-8 | 55154142508 | 2070 TABLET, FILM COATED in 1 BOTTLE (55154-1425-8) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5f76e16f-0c24-454a-81af-4080b312c940
Use it
Look up 55154-1425 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/55154-1425 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 55154-1425. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.